Results 211 to 220 of about 115,201 (249)

Chemical Bond‐Orchestrated Energy Depletion to Augment Lung Cancer Chemo‐Immunotherapy

Advanced Science, EarlyView.
This study grafted dichloroacetic acid (DCA) into perylenediimide (PDI) skeleton via ionic or covalent bond to create novel metabolic agent PDIC‐AC and PDIC‐NAC, explicitly elaborated the underlying energy metabolism and therapeutic mechanism, and developed a promising strategy for energy metabolism‐targeting chemo‐immunotherapy by chemical bond ...
Xuejie Zhao, Yuting Liu, Xiao Huang, Liwen Zhao, Chunli Li, Yongwei Huang   +5 more
wiley   +1 more source

Comprehensive characterization of the inflammatory ecosystems in immunotherapy-induced adverse events versus chronic inflammatory diseases. [PDF]

J Immunother Cancer
Kang J, An J, Choi JK.
europepmc   +1 more source

A Conserved Natural Killer Cell Transcriptional Fingerprint in Rhesus Macaque Models of Acute Viral Infections. [PDF]

AIDS Res Hum Retroviruses
Hudson A, Kroll K, Bimber B, Hueber B, Woolley G, Reeves RK.   +5 more
europepmc   +1 more source

Natural killer cell dysregulation in polycystic ovary syndrome: immunometabolic and reproductive implication. [PDF]

Front Immunol
Jiang N, Liu J, Li C, Wang X, Pang Y, Zhang X, Ma Y, Zhang S, Xu Y, Li Q, Sun Q, Tang P, Han L.   +12 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Immunotherapy with Cytokine-Induced Killer Cells in Metastatic Renal Cell Carcinoma

Cancer Biotherapy and Radiopharmaceuticals, 2010
Cytokine-induced killer (CIK) cells have shown antitumor activity against several tumor cells both in vitro and in vivo. This study reports on the large-scale expansion of CIK cells and also present preliminary results from a pilot clinical trial.
Xiaosan Su
exaly   +3 more sources

Cancer Immunotherapy with Cytokine-Induced Killer Cells

Targeted Oncology, 2017
Cytokine-induced killer (CIK) cells form under certain stimulation conditions in cultures of peripheral blood mononuclear cells (PBMCs). They are a heterogeneous immune cell population and contain a high percentage of cells with a mixed T-NK phenotype (CD3+CD56+).
Juan J, Mata-Molanes, Manuel, Sureda González, Belén, Valenzuela Jiménez, Elena Mª, Martínez Navarro, Antonio, Brugarolas Masllorens   +4 more
openaire   +2 more sources

Is there a Role for Cytokine-Induced Killer Cells in Cancer Immunotherapy?

Immunotherapy, 2012
867 ISSN 1750-743X 10.2217/IMT.12.89 © 2012 Future Medicine Ltd Immunotherapy (2012) 4(9), 867–869 “There is no doubt that the use of cytokine-induced killer cells holds promise but only the future will tell us whether this relatively simple form of adoptive cellular immunotherapy will really have an impact on the still dismal prognosis of patients ...
Rutella, Sergio, Locatelli, Franco
openaire   +2 more sources

Promising immunotherapy: Highlighting cytokine‐induced killer cells

Journal of Cellular Biochemistry, 2018
AbstractFor many years, cancer therapy has appeared to be a challenging issue for researchers and physicians. By the introduction of novel methods in immunotherapy, the prospect of cancer therapy even more explained than before. Cytokine‐induced killer (CIK) cell‐based immunotherapy demonstrated to have potentiality in improving clinical outcomes and ...
Solmaz Shirjang, Nazila Alizadeh, Behzad Mansoori, Ata Mahmoodpoor, Hossein Samadi Kafil, Mohammad Hojjat‐Farsangi, Mehdi Yousefi   +6 more
openaire   +2 more sources